Search research articles
Contact Us
Filters
Showing results (1-10 of 152) with videos related to
Page
of 16
Sort By:
Presse Medicale (Paris, France : 1983)
|
January 15, 2008
[Taxane-induced skin toxicity and TNF-alpha]
Olivier Mir, Julien Adam
JAMA Oncology
|
July 14, 2018
Optimal Multimodal Treatment for Desmoplastic Small Round Cell Tumors
Olivier Mir, Julien Adam, Charles Honoré
Annales De Pathologie
|
January 24, 2017
[Tissue biomarkers of response to anti-PD-1 immunotherapies in melanoma]
Julien Adam, Gorana Tomasic, Caroline Robert
The Lancet. Oncology
|
October 10, 2017
PD-1 inhibition in bone sarcoma and soft-tissue sarcoma
Olivier Mir, Charles Honoré, Julien Adam
Translational Lung Cancer Research
|
July 18, 2020
Selected highlights of the 2019 Pulmonary Pathology Society Biennial Meeting: PD-L1 test harmonization studies
Sylvie Lantuejoul, Francesca Damiola, Julien Adam
Journal of Thoracic Disease
|
February 19, 2019
Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma
Sylvie Lantuejoul, Diane Damotte, Véronique Hofman, et al.
World Journal of Urology
|
November 3, 2020
PD-L1 testing in urothelial bladder cancer: essentials of clinical practice
Mathieu Rouanne, Camélia Radulescu, Julien Adam, et al.
The Journal of Urology
|
November 28, 2017
Re: Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications: S. A. M. Wankowicz, L. Werner, A. Orsola, J. Novak, M. Bowden, T. K. Choueiri, I. de Torres, J. Morote, G. J. Freeman, S. Signoretti and J. Bellmunt J Urol 2017;198:817-823
Mathieu Rouanne, Thierry Lebret, Camélia Radulescu, et al.
Kidney International
|
December 1, 2011
The case ∣ a 69-year-old man with a 10-year history of idiopathic retroperitoneal fibrosis
Mohamad Zaidan, Julien Adam, Pascale Cervera-Pierot, et al.
Annales De Pathologie
|
March 12, 2019
[Recent updates regarding PD-L1 testing in non-small cell lung carcinoma]
Julien Adam, Fabien Forest, Audrey Mansuet-Lupo, et al.
Page
of 16
Search research articles
Search
Showing results (1-10 of 152) with videos related to
Sort By:
Page
of 16
Presse Medicale (Paris, France : 1983)
|
January 15, 2008
[Taxane-induced skin toxicity and TNF-alpha]
Olivier Mir, Julien Adam
JAMA Oncology
|
July 14, 2018
Optimal Multimodal Treatment for Desmoplastic Small Round Cell Tumors
Olivier Mir, Julien Adam, Charles Honoré
Annales De Pathologie
|
January 24, 2017
[Tissue biomarkers of response to anti-PD-1 immunotherapies in melanoma]
Julien Adam, Gorana Tomasic, Caroline Robert
The Lancet. Oncology
|
October 10, 2017
PD-1 inhibition in bone sarcoma and soft-tissue sarcoma
Olivier Mir, Charles Honoré, Julien Adam
Translational Lung Cancer Research
|
July 18, 2020
Selected highlights of the 2019 Pulmonary Pathology Society Biennial Meeting: PD-L1 test harmonization studies
Sylvie Lantuejoul, Francesca Damiola, Julien Adam
Journal of Thoracic Disease
|
February 19, 2019
Programmed death ligand 1 immunohistochemistry in non-small cell lung carcinoma
Sylvie Lantuejoul, Diane Damotte, Véronique Hofman, et al.
World Journal of Urology
|
November 3, 2020
PD-L1 testing in urothelial bladder cancer: essentials of clinical practice
Mathieu Rouanne, Camélia Radulescu, Julien Adam, et al.
The Journal of Urology
|
November 28, 2017
Re: Differential Expression of PD-L1 in High Grade T1 vs Muscle Invasive Bladder Carcinoma and its Prognostic Implications: S. A. M. Wankowicz, L. Werner, A. Orsola, J. Novak, M. Bowden, T. K. Choueiri, I. de Torres, J. Morote, G. J. Freeman, S. Signoretti and J. Bellmunt J Urol 2017;198:817-823
Mathieu Rouanne, Thierry Lebret, Camélia Radulescu, et al.
Kidney International
|
December 1, 2011
The case ∣ a 69-year-old man with a 10-year history of idiopathic retroperitoneal fibrosis
Mohamad Zaidan, Julien Adam, Pascale Cervera-Pierot, et al.
Annales De Pathologie
|
March 12, 2019
[Recent updates regarding PD-L1 testing in non-small cell lung carcinoma]
Julien Adam, Fabien Forest, Audrey Mansuet-Lupo, et al.
Page
of 16